Mosaic ImmunoEngineering (CPMV) Interest Coverage Ratio (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted Interest Coverage Ratio of 62.75 for Q1 2026, down 6.79% on a QoQ basis from 58.76 in Q4 2025, and up 11.46% year-over-year from 56.3 in Q1 2025.
Powered by 
Analysis
Mosaic ImmunoEngineering (CPMV) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering has reported Interest Coverage Ratio for 5 years, with the latest figure at 62.75 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 11.46% year-over-year to 62.75 in Q1 2026; TTM through Mar 2026 was 59.6, a 37.13% increase from a year earlier, with the FY2025 full-year figure at 61.61, up 51.3% from the prior year.
- Interest Coverage Ratio was 62.75 for Q1 2026 at Mosaic ImmunoEngineering, down from 58.76 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 49.99 in Q4 2024, with the low at 70.87 in Q1 2025.
- Average Interest Coverage Ratio over 3 years is 60.79, with a median of 59.71 recorded in 2025.
- The largest YoY upside for Interest Coverage Ratio was 13.48% in 2025 against a maximum downside of 17.55% in 2025.
- Over 3 years, Interest Coverage Ratio stood at 49.99 in 2024, then decreased by 17.55% to 58.76 in 2025, then declined by 6.79% to 62.75 in 2026.
- The last three Interest Coverage Ratio figures came in at 62.75 (Q1 2026), 58.76 (Q4 2025), and 57.26 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Mosaic ImmunoEngineering | 434,528.21 | 434,528.21 | - | -62.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -62.75 |
| Dec 31, 2025 | -58.76 |
| Sep 30, 2025 | -57.26 |
| Jun 30, 2025 | -59.71 |
| Mar 31, 2025 | -70.87 |
| Dec 31, 2024 | -49.99 |
| Sep 30, 2024 | -66.18 |
| Nov 30, 2011 | -3.53 |
| Aug 31, 2011 | -3.13 |
| Feb 28, 2011 | -0.42 |
| Nov 30, 2010 | -5.45 |
| Aug 31, 2010 | -0.91 |